Profiteering Off Public Health Crises: The Viable Cure for Congressional Insider Trading
This article takes an approachable, forward-thinking, and academic dive into congressional insider trading in the wake of the coronavirus (COVID-19) pandemic. After a confidential briefing by the Senate Health Committee warned of COVID-19, massive stock sell-offs by members of Congress and their spouses suddenly ensued. Some senators even publicly disparaged COVID-19’s viral effects while their own shares were being offloaded. By the time the American people were made aware of its dangers, vast investment holdings by congressional insiders had already been sold. Shockingly, it is unclear if congressional insiders trading on confidential coronavirus information are actually breaking the law. Congress members are also not required to timely disclose trades, even during pandemics, leaving the American people in the dark. This article provides the only viable remedy to congressional insider trading, crucial for governmental transparency and accountability to precipitously curb public health crises moving forward.
Charles L. Slamowitz, Profiteering Off Public Health Crises: The Viable Cure for Congressional Insider Trading, 77 Wash. & Lee L. Rev. Online 31 (2020), https://scholarlycommons.law.wlu.edu/wlulr-online/vol77/iss1/3
American Politics Commons, Health Law and Policy Commons, Legislation Commons, Securities Law Commons